27 phd-image-processing-"Multiple" Postdoctoral positions at University of Nebraska Medical Center
Sort by
Refine Your Search
-
fields include (but are not limited to) Computer Science, statistics, mathematics, automation, informatics, and Engineering. • Experience in deep learning, machine learning and medical imaging processing
-
Requisition Number: 2025 - 214 Business Unit: College of Medicine Department: Surgery-Cardiothoracic Surgery 50003926 Reg-Temp: Full-Time Regular Position Summary: The Department of Surgery at the University
-
efforts are directed at identifying and overcoming stromal barriers to treatment (including elevated interstitial pressures, activated fibroblasts, and multiple mechanisms of immune suppression
-
xenografts. Required Qualifications A postdoc applicant should have a PhD and prior experience in lung cancer and metastatic models and techniques, such as molecular biology, cell culture, biomarker analysis
-
to lead high-impact publications. Required Qualifications PhD in cancer biology, molecular/cellular biology, genomics, or immunology Expertise in Gene editing technology and NGS Flow cytometry and cell
-
, multidisciplinary collaborations, and opportunities to lead high-impact publications. Required Qualifications: PhD in cancer biology, molecular/cellular biology, genomics, or immunology Expertise in Gene editing
-
Qualifications PhD or MD/PhD in Molecular Cell Biology, Biochemistry, Cancer biology or a related discipline A strong experimental background with evidence of experimental skills related to cell biology, molecular
-
development of standardized methods for local and national application. Qualifications PhD in a relevant field such as climatology, environmental science, data science, public health, or a closely related
-
demonstrated independent thinking and problem-solving abilities. Experience using large databases is preferred, and genetic data analysis skills are desirable. Required Qualifications PhD or MD in Public Health
-
, activated fibroblasts, and multiple mechanisms of immune suppression); identifying and disrupting molecular drivers of metastasis; and developing immune-based treatment strategies. Our ultimate aim is to take